ACTIVE

Obulytix

Export PDF
Financial year 2025 · closed on 31/12/2025
Net result
-2,7 M €
-146.5% YoY
Gross margin
-2,1 M €
-259.2% YoY
Equity
2,2 M €
-42.0% YoY
Workforce
4,3 ETP
+65.4% YoY

What does Obulytix do?

Obulytix is a Private limited company incorporated in 2023. Its main activity is: Manufacture of pharmaceutical preparations. Its registered office is in Gent. It employs on average 4,3 ETP workers (FTE).

Legal situation
● Normal situation
BCE/KBO no. / VAT
BE 0803.351.624
Incorporation
29/06/2023
Legal form
Private limited company
Registered office
Suzanne Tassierstraat 1 box 3.4
9052 Gent · FlandreSee on map
Contributed capital
5 669 587,90 €
Latest accounts
31/12/2025
Average workforce
4,3 ETP
Activities (NACE)
21201Manufacture of pharmaceutical preparations· main21201Manufacture of pharmaceutical preparations72109Research and experimental development on natural sciences and engineering72190Other research and experimental development on natural sciences and engineering
Signals
Solid equityGood liquidityHealthy social debts
View the BCE/KBO Public Search record →
Health score
Available with a Rovalta subscriptionTry for 7 days
Recommended credit limit
✦ Verdict · Analyst summary
Financials

Trend over 2 financial years

20252024
Income statement
Gross margin-2,1 M €-590,5 k €
EBITDA-2,4 M €-843,3 k €
Operating result-2,7 M €-1,1 M €
Net result-2,7 M €-1,1 M €
Balance sheet
Equity2,2 M €3,8 M €
Total assets5,3 M €5,1 M €
Cash1,9 M €1,5 M €
Debts2,7 M €342,2 k €
Other
Workforce4,3 ETP2,6 ETP
Estimate

Indicative valuation

As an indication, this company is worth

between 1 M€ and 2,5 M€
See the valuation
Governance

Board of directors

Seen on filing of 31/12/2025 · 8 active · 1 ended

Active mandates

Philipp Müller

Director · since 01 octobre 2025

Active
Lisa Patel

Director · since 14 juillet 2025 · until 09 juin 2031

Active
Biotilia

Managing director · since 01 août 2024 · 0831.842.306

Represented by Kristof Van Emelen

Active
Bram Perdu

Director · since 26 juillet 2023

Active
Dominic De Groote

Director · since 26 juillet 2023

Active
Niklas Czeloth

Director · since 26 juillet 2023 · until 01 octobre 2025

Active
QBIC VENTURE PARTNERS III

Director · since 26 juillet 2023 · 0782.427.932

Represented by Cédric Van Nevel

Active
Yves Briers

Director · since 28 juin 2023

Active

Ended mandates

Niklas Czeloth

Director · since 26 juillet 2023

Ended
At this address

Other companies at this address

CompanyCBE no.
272BIO● Active
0762.638.249
AmphiStar● Active
0771.868.491
Biotope General Partner● Active
1023.886.864
Biotope Ventures● Active
0786.781.648
Biotope Ventures II● Active
1024.242.497
EU-LIFE● Active
1038.799.823
EU-SAGE● Active
0774.834.218
I-CHALLENGE● Active
1002.343.560
LO²CUS Gent● Active
0642.937.081
ORIONIS BIOSCIENCES● Active
0635.962.088
Rainbow Crops● Active
1022.560.538
S-Biomedic● Active
0668.407.105
Typcal Europe● Active
1028.922.352
VIB BIO-INCUBATOR● Active
0711.986.235
VLAAMS INSTITUUT VOOR BIOTECHNOLOGIE - FLANDERS INSTITUTE FOR BIOTECHNOLOGY● Active
0456.343.923
Xpert Protein● Active
1014.642.467
Annual accounts

Full financial information

20252024
Type of accountAbridged modelAbridged model
Start of the financial year01/01/202529/06/2023
Closing of the financial year31/12/202531/12/2024
Length of the financial year12 months19 months
Filing date22/06/202602/07/2025
General meeting08/06/202625/06/2025
Currency of the financial yearEUREUR
NBB quality labelSatisfying controlsSatisfying controls
Ratios

Financial ratios

Looking for more information about this company?

Try for 7 days
Filings

Annual accounts filings

2 filings with the NBB

ModelClosingGeneral meetingFiledLanguageDocument
Abridged model31/12/202508/06/202622/06/2026DutchPDF
Abridged model31/12/202425/06/202502/07/2025DutchPDF
Estimate

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 1 M€ and 2,5 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Governance

Board of directors

Seen on filing of 31/12/2025 · 8 active · 1 ended

Active mandates

Philipp Müller

Director · since 01 octobre 2025

Active
Lisa Patel

Director · since 14 juillet 2025 · until 09 juin 2031

Active
Biotilia

Managing director · since 01 août 2024 · 0831.842.306

Represented by Kristof Van Emelen

Active
Bram Perdu

Director · since 26 juillet 2023

Active
Dominic De Groote

Director · since 26 juillet 2023

Active
Niklas Czeloth

Director · since 26 juillet 2023 · until 01 octobre 2025

Active
QBIC VENTURE PARTNERS III

Director · since 26 juillet 2023 · 0782.427.932

Represented by Cédric Van Nevel

Active
Yves Briers

Director · since 28 juin 2023

Active

Ended mandates

Niklas Czeloth

Director · since 26 juillet 2023

Ended
Shareholders

Ownership and network

Looking for more information about this company?

Try for 7 days
Belgian Official Gazette

Belgian Official Gazette publications

  • Mandates19/12/2025
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Capital / shares10/11/2025
    STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, …) - KAPITAAL - AANDELEN
    PDF
  • Mandates27/10/2025
    MAATSCHAPPELIJKE ZETEL - ONTSLAGEN - BENOEMINGEN
    PDF
  • Mandates01/10/2024
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Mandates02/07/2024
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Other05/03/2024
    STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, …) - BENAMING
    PDF
  • Mandates07/08/2023
    STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, …) - KAPITAAL - AANDELEN - ONTSLAGEN - BENOEMINGEN
    PDF
  • Other03/07/2023
    RUBRIEK OPRICHTING (NIEUWE RECHTSPERSOON, OPENING BIJKANTOOR, ENZ...)
    PDF

Source: Belgian Official Gazette

Competition

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

  1. 2025
    Annual accounts 2025-2,7 M €↓
  2. 2024
    Annual accounts 2024-1,1 M €
  3. 29/06/2023
    IncorporationPrivate limited company